MedImmune CEO Peter Greenleaf, Human Genome Sciences, Inc. CEO Tom Watkins, Montgomery County, Maryland Executive Isiah Leggett Come Together in the Maryland Pavilion at the 2012 Biotechnology Industry Organization (BIO)

ROCKVILLE, MD– June 14, 2012 — The Montgomery County Department of Economic Development will host a press event highlighting the nation’s first local biotech investment incentive program, initiated by Montgomery County government, the role local biotech entrepreneurs, many from County-based federal labs like NIH and FDA, play in the success of the sector and a new, regional, industry-sector led intermediary created to bolster technology transfer into commercial success during the BIO International Convention in Boston.

WHEN: Tuesday, June 19, 2012 from 3:00-4:30pm EDT.

WHERE: The Boston Convention and Exhibition Center, MA - Maryland Pavilion

WHAT: Press event featuring: MedImmune CEO Peter Greenleaf discussing the growth and success of that company in Montgomery County and that company’s leading role in supporting the newly formed BioHealth Innovation, Inc. (BHI) - an industry-lead biotech intermediary; Human Genome Sciences CEO Tom Watkins discussing the growth and success of that company in Montgomery County and the supportive local government and innovative initiatives and policies that support the sector; Montgomery County Executive Isiah Leggett discussing the success of the County’s local biotech investment incentive program and BHI Board Chair Scott Carmer, Executive Vice President, Commercial Operations for MedImmune and BHI CEO Rich Bendis discussing the early initiatives and successes of that new regional entity in bolstering the success of the region’s biotech sector.

In addition, the Montgomery County Department of Economic Development press event will also include:

• The key role the biotech industry is playing in the evolution of entrepreneurship, with Peter Greenleaf, CEO of MedImmune moderating an impressive panel of five serial biotech entrepreneurs including: Mark Rampy, CEO of CohBar, Inc.; John Trizzino, CEO of ImmunoVaccine; Ken Carter, President & CEO of NexImmune, Inc.; Peter Kiener, President & CEO of Zyngenia; and Rahul Singhvi, Co-Founder of BioCycive;

• A chance for biotech companies to win 6 months FREE lab space in one of the County’s leading incubator facilities that make up the Montgomery County Business Innovation Network – one of the nation’s largest and most successful incubator programs with some 170 companies supporting nearly 670 county-based jobs. Since inception in 2000, more than 100 companies have graduated from the Network. These companies currently occupy nearly 700,000 square feet of commercial space in Montgomery County and have added more than 2,000 jobs to the local economy. For press inquiry the day of the press event, please contact: Kristina Ellis, Montgomery County Dept. of Economic Development at 240-793-9568 or via e-mail

About Montgomery County Department of Economic Development The Montgomery County Department of Economic Development is charged with implementing the County’s economic development vision of being a globally-competitive, highly-diversified and knowledge-based economy that provides for the retention and growth of existing companies, stimulates new job creation and enhances entrepreneurial opportunities for all businesses. The Department offers a broad range of programs, services, partnering opportunities and strategic financing resources to stimulate and expand the County’s business, job and tax base. To learn more, visit

About the Biotechnology Industry Organization (BIO) Biotechnology researchers expand the boundaries of science to benefit mankind by providing better healthcare, enhanced agriculture, and a cleaner and safer environment. The mission of the Biotechnology Industry Organization (BIO) is to be the champion of biotechnology and the advocate for its member organizations both large and small. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. For more information about BIO, please visit

Back to news